The Future of Commercial Teams: Adapting to the Healthcare Landscape in a COVID-19 World
The pandemic created significant challenges for life sciences commercial teams. Face-to-face interactions that traditionally were the mainstay of sales, market access, and patient services operations were not possible during stay-at-home orders, travel bans, and social distancing. Moreover, accounts in different regions of the country experienced peak numbers of patients with COVID-19 at different times, requiring sales reps and other members of commercial teams to maintain agility while providing the pharmaceuticals and services that healthcare providers needed most.
Watch this on-demand webinar to learn:
- How commercial teams are adapting during the pandemic
- How teams can use data to streamline processes and increase visibility
- New tools and training that commercial teams require
- How teams are moving forward in the new normal
Watch this webinar to hear from industry thought leaders how commercial teams balanced compliance with remote work with new ways to interact with and engage their customers.
People also viewed
Customer Centricity and Digital Experiences which are Redefining Pharma
It is no secret that the pharmaceutical industry has historically flourished from blockbuster products with substantial brand equity, favorable pricing
Awash in Data, Yet Starving for Insights? Transform Life Sciences Commercial Teams with AI-Powered Analytics
Personalized communication is something the HCPs have come to expect. To do that, pharma sales reps need to know their customers well. In order to know the customer well, they need data. Enterprise pharma companies, however, have many data resources and lots of data at their disposal. In fact, there is a data explosion. So what do you do?
Readiness of Augmented Analytics for Life Sciences Commercial Teams
Demand for smart, agile, and near-instant commercial analytics in Pharma is rising. More contextual, continuous, and connected data and analytics are required to respond to more complex and uncertain business decisions.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Where Gartner Positions Natural Language Query on the Hype Cycle and What It Means for Life Sciences
Gartner® 2022 Hype Cycle™ for Natural Language Technologies (NLT) shows natural language query (NLQ) adoption is accelerating. WhizAI was recently recognized as a Sample Vendor in the Natural Language Query category in several Gartner Hype Cycles:
AI Powered Business Intelligence for Life Science Leaders: Save Time, Drive Adoption and Scale Faster
Today’s commercial teams must pinpoint top opportunities in markets across the country—or across the world—based on regulations, drug trials, market activity, competitors, insurance records, HCP preferences and affiliations, much more data than is humanly possible to manage.